Monday, October 6, 2008
New Regulations for Pharmaceutical Advertisements
This article has to do with drug advertisement regulation, a topic we discussed a few weeks ago in class. The article, Doctoring Drug Ads by Jennifer Wedekind, was featured in the Multinational Monitor September/October 2008 issue. According to the article, drug manufactures have agreed to new advertisement regulation after pressure from lawmakers. In June, the manufactures agreed to wait six months, after FDA approval, to advertise new drugs directly to the consumer. Furthermore, there will be stricter regulations on how doctors are used in the ads. If the doctor in the advertisement is an actor, under the new regulation this must be stated in the ad. And, if the doctor is an actual physician the ad must state whether he/she was compensated to appear in the ad. These new regulations came about due to the Vioxx disaster that killed between 35,000 and 55,000 people.
Subscribe to:
Post Comments (Atom)
1 comment:
What this blog doesn't mention is that the six month waiting period following FDA approval for new drugs has been a voluntary industry guideline (developed by the Pharmaceutical manufacturer's Association) for some time. This is an example of industry self-policing that was successful in pre-empting a much longer wiating period that FDA initially proposed several years ago. Christy Beckmann
Post a Comment